MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 128 filers reported holding MACROGENICS INC in Q4 2015. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $242,040 | -4.4% | 51,940 | +9.7% | 0.00% | – |
| Q2 2023 | $253,259 | -22.9% | 47,338 | +3.4% | 0.00% | – |
| Q1 2023 | $328,364 | -10.6% | 45,797 | -16.4% | 0.00% | -100.0% |
| Q4 2022 | $367,366 | +55.7% | 54,749 | -19.7% | 0.00% | – |
| Q3 2022 | $235,916 | -17.5% | 68,184 | -29.7% | 0.00% | -100.0% |
| Q2 2022 | $286,000 | -16.1% | 96,979 | +150.5% | 0.00% | 0.0% |
| Q1 2022 | $341,000 | -33.3% | 38,715 | +21.5% | 0.00% | 0.0% |
| Q4 2021 | $511,000 | -22.1% | 31,869 | +1.8% | 0.00% | 0.0% |
| Q3 2021 | $656,000 | -21.3% | 31,313 | +0.8% | 0.00% | -50.0% |
| Q2 2021 | $834,000 | -7.5% | 31,073 | +9.7% | 0.00% | 0.0% |
| Q1 2021 | $902,000 | +33.8% | 28,330 | -3.9% | 0.00% | +100.0% |
| Q4 2020 | $674,000 | +11.2% | 29,481 | +22.5% | 0.00% | 0.0% |
| Q3 2020 | $606,000 | +30.6% | 24,074 | +45.0% | 0.00% | 0.0% |
| Q2 2020 | $464,000 | +254.2% | 16,608 | -26.3% | 0.00% | – |
| Q1 2020 | $131,000 | -46.5% | 22,549 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $245,000 | +7.5% | 22,549 | +26.3% | 0.00% | – |
| Q3 2019 | $228,000 | -24.8% | 17,857 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $303,000 | +3.1% | 17,857 | +9.1% | 0.00% | 0.0% |
| Q1 2019 | $294,000 | -87.5% | 16,370 | -91.1% | 0.00% | -83.3% |
| Q4 2018 | $2,346,000 | -88.0% | 184,693 | -79.8% | 0.01% | -85.0% |
| Q3 2018 | $19,574,000 | +4.7% | 912,978 | +0.8% | 0.04% | 0.0% |
| Q2 2018 | $18,703,000 | +104.5% | 905,752 | +149.2% | 0.04% | +100.0% |
| Q1 2018 | $9,144,000 | -16.6% | 363,433 | -37.0% | 0.02% | -13.0% |
| Q4 2017 | $10,967,000 | +18.0% | 577,181 | +14.7% | 0.02% | +15.0% |
| Q3 2017 | $9,298,000 | +46.8% | 503,145 | +39.1% | 0.02% | +42.9% |
| Q2 2017 | $6,332,000 | -2.9% | 361,633 | +3.2% | 0.01% | -6.7% |
| Q1 2017 | $6,518,000 | -5.3% | 350,439 | +4.1% | 0.02% | -6.2% |
| Q4 2016 | $6,882,000 | -32.7% | 336,697 | -1.5% | 0.02% | -15.8% |
| Q3 2016 | $10,221,000 | +4.3% | 341,709 | -5.9% | 0.02% | -20.8% |
| Q2 2016 | $9,799,000 | +67.0% | 363,059 | +16.0% | 0.02% | +60.0% |
| Q1 2016 | $5,868,000 | -54.4% | 312,964 | -24.7% | 0.02% | -51.6% |
| Q4 2015 | $12,877,000 | +42.1% | 415,814 | -1.7% | 0.03% | +34.8% |
| Q3 2015 | $9,059,000 | -19.7% | 422,914 | +42.4% | 0.02% | -11.5% |
| Q2 2015 | $11,278,000 | +46.1% | 297,039 | +20.7% | 0.03% | +52.9% |
| Q1 2015 | $7,719,000 | +1791.9% | 246,075 | +2016.8% | 0.02% | +1600.0% |
| Q4 2014 | $408,000 | +67.9% | 11,625 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $243,000 | -4.0% | 11,625 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $253,000 | – | 11,625 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 2,115,000 | $37,034,000 | 8.81% |
| INTERWEST VENTURE MANAGEMENT CO | 1,074,316 | $18,811,000 | 4.45% |
| DAFNA Capital Management LLC | 119,200 | $2,087,000 | 1.49% |
| BB BIOTECH AG | 2,350,112 | $41,150,000 | 1.26% |
| TIGER MANAGEMENT L.L.C. | 239,667 | $4,197,000 | 0.82% |
| Hood River Capital Management LLC | 576,193 | $10,089,000 | 0.70% |
| Bellevue Group AG | 316,418 | $5,540,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 175,000 | $3,064,000 | 0.44% |
| First Light Asset Management, LLC | 61,538 | $1,078,000 | 0.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 54,000 | $945,000 | 0.36% |